St. Marianna University School of Medicine;Kyowa Kirin Co., Ltd.
发明人:
Yamano, Yoshihisa
申请号:
AU2018228246
公开号:
AU2018228246A1
申请日:
2018.03.02
申请国别(地区):
AU
年份:
2019
代理人:
摘要:
The purpose of the present invention is to provide a novel therapeutic or preventive agent for human T-cell leukemia virus-1-associated myelopathy (HAM), characterized by containing an anti-human CC-chemokine receptor 4 (CCR4) antibody or a fragment of the antibody as an active ingredient and by a dosage regimen of said antibody or of a fragment of the antibody. The present invention pertains to a therapeutic or preventative agent for HAM, which is characterized by containing an anti-human CCR4 antibody or a fragment of the antibody as an active ingredient and in that the antibody or fragment of the antibody is administered at a low dose.